Embryonic stem cells have come to represent potential salvation for many people suffering from incurable diseases. State governments, most notably California with the passage of Prop 71, have taken the unusual step of funding biomedical research – usually done with federal grants – because of federal decisions to restrict funding. Recently President Obama signed an executive order ending an 8½-year ban on federal funding for the creation of new embryonic stem cell lines, paving the way for a significant amount of federal funds for the new research and development possibilities. With the climate for stem-cell research funding changing rapidly, a panel of industry executives will discuss funding opportunities – in the state of California, nationally and internationally, how companies can directly benefit and what pitfalls to avoid.

What: Therapeutic Breakfast Series Funding for Stem-Cell Research: a Changing Landscape When: October 22, 2009 | 8:00 - 10:00am Where: Elan Pharmaceuticals, Inc. 180 Oyster Point Blvd. South San Francisco, CA, 94080 Directions Parking: Free parking Attire: Business attire suggested Cost: Early Bird Registration through Oct. 20: $10.00 - BayBio Members $20.00 - Non-Members On-Site Registration, Oct. 22: $20.00 - BayBio Members $40.00 - Non-Members

Registration (If you are an employee of a Partner or Sponsor company, please contact Program Director, Misha Tsirulnikov to obtain your complimentary registration.)

• Pre-registered attendees will receive an immediate receipt/confirmation after submission.
• Please print this receipt/confirmation and bring it with you to receive your conference credentials.
• Photo ID (driver's license or passport) will be required at check-in.
• All sales are final - BayBio offers no refunds

Please mail your event-related questions to: events@baybio.org or you can contact us via phone: 650-871-7101.

Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!